Effect of themicrobial lipopeptide on tumor cell lines: Apoptosis induced by disturbing the fatty acid composition of cell membrane

Protein and Cell

Volumn 1, Issue 6, 2010, Pages 584-594

  Liu, Xiangyang ^a,b   Tao, Xinyi ^a   Zou, Aihua ^a   Yang, Shizhong ^a   Zhang, Lixin ^b   Mu, Bozhong ^a  

^a EAST CHINA UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b INSTITUTE OF MICROBIOLOGY   (China)

Author keywords

antitumor activity; apoptosis; Bacillus subtilis; lipopeptide; membrane fatty acid

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; 4 [5 (4 METHYL 1 PIPERAZINYL)[2,5' BI 1H BENZIMIDAZOL] 2' YL]PHENOL; FATTY ACID; HSO 121; LIPOPEPTIDE; UNCLASSIFIED DRUG; ANTINEOPLASTIC AGENT;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BACILLUS SUBTILIS; BREAST CANCER; CANCER CELL CULTURE; CELL MEMBRANE; CELL STRUCTURE; COLORIMETRY; CONCENTRATION RESPONSE; CONTROLLED STUDY; CRITICAL MICELLE CONCENTRATION; CYTOCHEMISTRY; CYTOLYSIS; CYTOTOXICITY; DRUG STRUCTURE; FLOW CYTOMETRY; GAS CHROMATOGRAPHY; GROWTH INHIBITION; HUMAN; HUMAN CELL; IC 50; LIPID COMPOSITION; LIVER CANCER; MASS SPECTROMETRY; MELANOMA; NONHUMAN; PANCREAS CANCER; PRIORITY JOURNAL; RAT; SQUAMOUS CELL CARCINOMA; SURFACE TENSION; UTERINE CERVIX CANCER; CELL CYCLE; CELL SURVIVAL; CHEMISTRY; DRUG EFFECT; HELA CELL; METABOLISM; PLOIDY; TUMOR CELL CULTURE;

BACILLUS SUBTILIS;

ANTINEOPLASTIC AGENTS; APOPTOSIS; BACILLUS SUBTILIS; CELL CYCLE; CELL MEMBRANE; CELL SURVIVAL; FATTY ACIDS; HELA CELLS; HUMANS; LIPOPEPTIDES; PLOIDIES; TUMOR CELLS, CULTURED;

EID: 79953164982     PISSN: 1674800X     EISSN: 16748018     Source Type: Journal    
DOI: 10.1007/s13238-010-0072-4     Document Type: Article

References (48)

1. Ando, H., Wen, Z. M., Kim, H. Y., Valencia, J. C., Costin, G. E., Watabe, H., Yasumoto, K., Niki, Y., Kondoh, H., Ichihashi, M., et al. (2006). Intracellular composition of fatty acid affects the processing and function of tyrosinase through the ubiquitin-proteasome pathway. Biochem J 394, 43-50.
2. Arima, K., Kakinuma, A., and Tamura, G. (1968). Surfactin, a crystalline peptidelipid surfactant produced by Bacillus subtilis: isolation, characterization and its inhibition of fibrin clot formation. Biochem Biophys Res Commun 31, 488-494.
3. Bligh, E. G., and Dyer, W. J. (1959). A rapid method of total lipid extraction and purification. Can J Biochem Physiol 37, 911-917.
4. Bonmatin, J. M., Laprévote, O., and Peypoux, F. (2003). Diversity among microbial cyclic lipopeptides: iturins and surfactins. Activitystructure relationships to design new bioactive agents. Comb Chem High Throughput Screen 6, 541-556.
5. Bortolato, M., Besson, F., and Roux, B. (1997). Inhibition of alkaline phosphatase by surfactin, a natural chelating lipopeptide from Bacillus subtilis. Biotechnol Lett 19, 433-435.
6. Cao, X., Wang, A. H., Jiao, R. Z., Wang, C. L., Mao, D. Z., Yan, L., and Zeng, B. (2009a). Surfactin induces apoptosis and G(2)/M arrest in human breast cancer MCF-7 cells through cell cycle factor regulation. Cell Biochem Biophys 55, 163-171.
7. Cao, X. H., Liao, Z. Y., Wang, C. L., Cai, P., Yang, W. Y., Lu, M. F., and Huang, G. W. (2009b). Purification and antitumour activity of a lipopeptide biosurfactant produced by Bacillus natto TK-1. Biotechnol Appl Biochem 52, 97-106.
8. Cao, X. H., Liao, Z. Y., Wang, C. L., Yang, W. Y., and Lu, M. F. (2009c). Evaluation of a lipopeptide biosurfactant from Bacillus natto Tk-1 as a potential source of anti-adhesive. Antimicrobial and Antitumor Activities. Braz J Microbiol 40, 373-379.
9. Cao, X. H., Wang, A. H., Wang, C. L., Mao, D. Z., Lu, M. F., Cui, Y. Q., and Jiao, R. Z. (2010). Surfactin induces apoptosis in human breast cancer MCF-7 cells through a ROS/JNK-mediated mitochondrial/caspase pathway. Chem Biol Interact 183, 357-362.
10. Carrillo, C., Teruel, J. A., Aranda, F. J., and Ortiz, A. (2003). Molecular mechanism of membrane permeabilization by the peptide antibiotic surfactin. Biochim Biophys Acta 1611, 91-97.
11. Dai, R. J., Phillips, R. A., Zhang, Y., Khan, D., Crasta, O., and Ahmed, S. A. (2008). Suppression of LPS-induced Interferon-gamma and nitric oxide in splenic lymphocytes by select estrogen-regulated microRNAs: a novel mechanism of immune modulation. Blood 112, 4591-4597.
12. Deleu, M., Bouffioux, O., Razafindralambo, H., Paquot, M., Hbid, C., Thonart, P., Jacques, P., and Brasseur, R. (2003). Interaction of surfactin with membranes: a computational approach. Langmuir 19, 3377-3385.
13. Dufour, S., Deleu, M., Nott, K., Wathelet, B., Thonart, P., and Paquot, M. (2005). Hemolytic activity of new linear surfactin analogs in relation to their physico-chemical properties. Biochim Biophys Acta 1726, 87-95.
14. Eeman, M., Berquand, A., Dufrêne, Y. F., Paquot, M., Dufour, S., and Deleu, M. (2006). Penetration of surfactin into phospholipid monolayers: nanoscale interfacial organization. Langmuir 22, 11337-11345.
15. Elstein, K. H., Thomas, D. J., and Zucker, R. M. (1995). Factors affecting flow cytometric detection of apoptotic nuclei by DNA analysis. Cytometry 21, 170-176.
16. Geiser, F., McAllan, B. M., and Kenagy, G. J. (1994). The degree of dietary fatty acid unsaturation affects torpor patterns and lipid composition of a hibernator. J Comp Physiol B 164, 299-305.
17. Geyer, R. P., Bennett, A., and Rohr, A. (1962). Fatty acids of the triglycerides and phospholipids of HeLa cells and strain L fibroblasts. J Lipid Res 3, 80-83.
18. Gong, J., Traganos, F., and Darzynkiewicz, Z. (1994). A selective procedure for DNA extraction from apoptotic cells applicable for gel electrophoresis and flow cytometry. Anal Biochem 218, 314-319.
19. Gorczyca, W., Gong, J., and Darzynkiewicz, Z. (1993). Detection of DNA strand breaks in individual apoptotic cells by the in situ terminal deoxynucleotidyl transferase and nick translation assays. Cancer Res 53, 1945-1951.
20. Grau, A., Gómez Fernández, J. C., Peypoux, F., and Ortiz, A. (1999). A study on the interactions of surfactin with phospholipid vesicles. Biochim Biophys Acta 1418, 307-319.
21. Haddad, N. I. A., Liu, X. Y., Yang, S. Z., and Mu, B. Z. (2008). Surfactin isoforms from Bacillus subtilis HSO121: separation and characterization. Protein Pept Lett 15, 265-269.
22. Hagve, T. A. (1988). Effects of unsaturated fatty acids on cell membrane functions. Scand J Clin Lab Invest 48, 381-388.
23. Heerklotz, H., and Seelig, J. (2001). Detergent-like action of the antibiotic peptide surfactin on lipid membranes. Biophys J 81, 1547-1554.
24. Heerklotz, H., and Seelig, J. (2007). Leakage and lysis of lipid membranes induced by the lipopeptide surfactin. Eur Biophys J 36, 305-314.
25. Howlett, N. G., and Avery, S. V. (1997). Relationship between cadmium sensitivity and degree of plasma membrane fatty acid unsaturation in Saccharomyces cerevisiae. Appl Microbiol Biotechnol 48, 539-545.
26. Huang, X. Q., Lu, Z. X., Zhao, H. Z., Bie, X. M., Xia, L. F., and Yang, S. J. (2006). Antiviral activity of antimicrobial lipopeptide from Bacillus subtilis fmbj against Pseudorabies Virus, Porcine Parvovirus, Newcastle Disease Virus and Infectious Bursal Disease Virus in Vitro. Int J Pept Res Ther 12, 373-377.
27. Kameda, Y., Oira, S., Matsui, K., Kanatomo, S., and Hase, T. (1974). Antitumor activity of bacillus natto. V. Isolation and characterization of surfactin in the culture medium of Bacillus natto KMD 2311. Chem Pharm Bull (Tokyo) 22, 938-944.
28. Kikuchi, T., and Hasumi, K. (2002). Enhancement of plasminogen activation by surfactin C: augmentation of fibrinolysis in vitro and in vivo. Biochim Biophys Acta 1596, 234-245.
29. Kim, S. Y., Kim, J. Y., Kim, S. H., Bae, H. J., Yi, H., Yoon, S. H., Koo, B. S., Kwon, M., Cho, J. Y., Lee, C. E., et al. (2007). Surfactin from Bacillus subtilis displays anti-proliferative effect via apoptosis induction, cell cycle arrest and survival signaling suppression. FEBS Lett 581, 865-871.
30. Kuo, M. T. (2009). Redox regulation of multidrug resistance in cancer chemotherapy: molecular mechanisms and therapeutic opportunities. Antioxid Redox Signal 11, 99-133.
31. Liu, X. Y., Haddad, N. I. A., Yang, S. Z., and Mu, B. Z. (2007). Structural characterization of eight cyclic lipopeptides produced by Bacillus subtilis HSO121. Protein Pept Lett 14, 766-773.
32. 12-lipopeptide produced by Bacillus subtilis HSO 121. J Pept Sci 14, 864-875.
33. Marsh, S., and McLeod, H. L. (2007). Pharmacogenetics and oncology treatment for breast cancer. Expert Opin Pharmacother 8, 119-127.
34. Menendez, J. A., Vellon, L., and Lupu, R. (2005). Targeting fatty acid synthase-driven lipid rafts: a novel strategy to overcome trastuzumab resistance in breast cancer cells. Med Hypotheses 64, 997-1001.
35. Michel, V., and Bakovic, M. (2007). Lipid rafts in health and disease. Biol Cell 99, 129-140.
36. Mosmann, T. (1983). Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65, 55-63.
37. Pelz, K., Hopfener, K., Wiedmann-Al-Ahmad, M., Jahnke, H., Wittmer, A., and Otten, J. E. (2006). Differences in the fatty acid composition of KB-cells and gingival keratinocytes is culture medium additive dependent. Biomed Chromatogr 20, 870-880.
38. Qi, L. F., Xu, Z. R., and Chen, M. L. (2007). In vitro and in vivo suppression of hepatocellular carcinoma growth by chitosan nanoparticles. Eur J Cancer 43, 184-193.
39. Rakheja, D., Kapur, P., Hoang, M. P., Roy, L. C., and Bennett, M. J. (2005). Increased ratio of saturated to unsaturated C18 fatty acids in colonic adenocarcinoma: implications for cryotherapy and lipid raft function. Med Hypotheses 65, 1120-1123.
40. Savage, P. B., Li, C., Taotafa, U., Ding, B., and Guan, Q. (2002). Antibacterial properties of cationic steroid antibiotics. FEMS Microbiol Lett 217, 1-7.
41. Schlager, S. I., Ohanian, S. H., and Borsos, T. (1978). Correlation between the ability of tumor cells to incorporate specific fatty acids and their sensitivity to killing by a specific antibody plus guinea pig complement. J Natl Cancer Inst 61, 931-934.
42. Sheppard, J. D., Jumarie, C., Cooper, D. G., and Laprade, R. (1991). Ionic channels induced by surfactin in planar lipid bilayer membranes. Biochim Biophys Acta 1064, 13-23.
43. Singletary, S. E. (2008). Breast cancer management: the road to today. Cancer 113, 1844-1849.
44. Vaara, M. (1992). Agents that increase the permeability of the outer membrane. Microbiol Rev 56, 395-411.
45. Vollenbroich, D., Pauli, G., Özel, M., and Vater, J. (1997). Antimycoplasma properties and application in cell culture of surfactin, a lipopeptide antibiotic from Bacillus subtilis. Appl Environ Microbiol 63, 44-49.
46. Walker, P. R., Kwast-Welfeld, J., Gourdeau, H., Leblanc, J., Neugebauer, W., and Sikorska, M. (1993). Relationship between apoptosis and the cell cycle in lymphocytes: roles of protein kinase C, tyrosine phosphorylation, and AP1. Exp Cell Res 207, 142-151.
47. Wang, C. L., Ng, T. B., Yuan, F., Liu, Z. K., and Liu, F. (2007). Induction of apoptosis in human leukemia K562 cells by cyclic lipopeptide from Bacillus subtilis natto T-2. Peptides 28, 1344-1350.
48. Ye, C. L., Liu, J. W., Wei, D. Z., Lu, Y. H., and Qian, F. (2004). In vitro anti-tumor activity of 2′, 4′-dihydroxy-6′-methoxy-3′, 5′-dimethylchalcone against six established human cancer cell lines. Pharmacol Res 50, 505-510.